A practical hub for clinic owners, aesthetic and dental practices, and the agencies that market them across Europe. Medical advertising law is national, fragmented, and enforced locally — a phrase that is routine in one country can trigger fines in another. This hub explains the risk and points you to the exact rules for each market you advertise into.
Each country guide below covers the same practical ground for one market: the phrases that get clinics reported or fined, the trigger words in the local language, what you can safely rewrite them to, the grey areas that need judgement, and who enforces the rules. The guides are written for marketers, not lawyers — plain-language risk guidance, not legal certification.
The single most misunderstood point in European clinic marketing: you comply with the law of the market you advertise into, not the country your clinic sits in. A Budapest clinic running German-language ads for German patients answers to Germany’s HWG — not Hungarian law. This hub exists to make that visible before it costs you.
| Market | Risk level | What bites most often | Guide |
|---|---|---|---|
| 🇩🇪 Germany | High | Strictest in the EU — blanket before/after ban, now extended to filler procedures and organic social posts (HWG). | Germany rules → |
| 🇦🇹 Austria | Medium-High | Three frameworks stack (ÄrzteG, ÄsthOpG, UWG); price-promotional language for procedures is fined. | Austria rules → |
| 🇨🇭 Switzerland | Medium | Cantonal variation on top of MedBG + FMH code; before/after restricted (explicit ban in Geneva for botulinum toxin). | Switzerland rules → |
| 🇫🇷 France | High (aesthetics) | Absolute ban on influencer promotion of aesthetic acts (Loi 2023-451); dedicated DGCCRF enforcement brigade. | France rules → |
| 🇧🇪 Belgium | High (aesthetics) | Near-total advertising prohibition for aesthetic medicine — only factual, objective, discreet information is permitted. | Belgium rules → |
| 🇳🇱 Netherlands | Medium-High | Price-promotion prohibition (CCBA); advertising injectables escalates you into Wet BIG public-health analysis. | Netherlands rules → |
| 🇭🇺 Hungary | Medium-High (outbound) | One post can breach four statutes at once; highest exposure is cross-border ads aimed at German-speaking patients. | Hungary rules → |
| 🇵🇱 Poland | High (clinic-level) | Dual-layer system: statutory entity-level ad ban + KEL 2025 ethics code; UOKiK fines up to 10% of turnover. | Poland rules → |
| 🇷🇴 Romania | High | New 2026 CMR Code: advertising must be «exclusively informative»; physician image tied to discounts is expressly banned. | Romania rules → |
| 🇬🇧 United Kingdom | High | CAP + MHRA + CMA; direct fines up to 10% of global turnover; naming Botox or weight-loss injections in public ads is illegal. | UK rules → |
Guides for Slovakia, Italy, Spain, and Ireland are in preparation. Advertising into a market not listed yet? It is still safer to assume the destination country’s rules apply — reach out and we can prioritise it.
Legal disclaimer: This hub and the guides it links to provide general information about European medical advertising regulations for educational purposes only and do not constitute legal advice. Regulations change and are enforced nationally. Verify all requirements with a qualified legal professional in the relevant jurisdiction before publishing any marketing materials. MedicalServiceFinder.com accepts no liability for decisions made based on this content.
Last updated: July 2026 | Coverage: DE, AT, CH, FR, BE, NL, HU, PL, RO, UK — expanding.
